Get Started

ELVN

NASD Enliven Therapeutics, Inc.
Oct 26, 2026 · 8:42 AM ET LAST TRADE Market Closed

$41.70 ↑ +0.18 (+0.43%) Trading Up from the previous close of $41.52

YTD change
+170.78%
vs 20-day SMA
-1.17%
vs 200-day SMA
-1.34%

Price ranges

Previous day
$40.82 $41.64
open $41.49 close $41.52
+$0.03 (+0.07%)
Today
$0.00 $0.00
$41.70
Past week
$37.32 $42.92
from $37.32 now $41.70
+$4.38 (+11.74%)
Past month
$36.96 $47.43
from $44.75 now $41.70
-$3.05 (-6.82%)
This year
$14.79 $62.32
from $15.40 now $41.70
+$26.30 (+170.78%)

Price & Performance

-3.38 (-7.53%) / 6M

$31.43$42.07$52.71$63.35Apr 27Jul 27Oct 23

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Very Good
  • The stock is 33.1% away from all-time highs of $62.32
  • ELVN is up 171% since the beginning of the year
  • ELVN is up 102% over the past 12 months
  • ELVN is down 7% over the past 1 month
  • 18% of all ELVN investors are betting against ELVN

ELVN reads very good: price sits below both the 20- and 200-day averages, the 12-month move is +94.0%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.49
Earnings momentum -9.4% Quarterly EPS growth
Quarterly change -9.4%

Valuation

P/E ratio N/A
Enterprise value $1.9B
Beta -0.07

Balance sheet & scale

IncomeN/A
RevenueN/A
Cash$895.2M
Debt$1.5K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $3.1B

Enliven Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovery and development of small molecule therapeutics. Its pipeline includes BCR-ABL Program: ELVN-001and HER2 Program: ELVN-002. The company was founded by Samuel S. Kintz, Joseph P. Lyssikatos, and Anish Patel on June 1, 2019 and is headquartered in Boulder, CO.

Competitor comparison

TickerCompany PriceChange
AMGN Amgen Inc. $439.26 -1.79%
MRNA Moderna, Inc. $200.10 -1.25%
RVMD Revolution Medicines, Inc. $186.99 -0.37%
ROIV Roivant Sciences Ltd. $36.49 -2.56%
BNTX BioNTech SE Sponsored ADR $88.12 -1.73%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.